TrueBlue Reports Wider Q4 Net Loss and Sharp Adjusted EBITDA Decline Amid Revenue Growth
summarizeSummary
TrueBlue, Inc. reported an increased net loss and a significant drop in Adjusted EBITDA for Q4 2025, despite an 8% rise in revenue, alongside a challenging Q1 2026 outlook for gross margin.
check_boxKey Events
-
Q4 2025 Net Loss Widens Significantly
Net loss for Q4 2025 increased to $32 million, up from $12 million in the prior year period, primarily due to an $18 million non-cash impairment charge on right-of-use and long-lived assets.
-
Adjusted EBITDA Declines Sharply
Adjusted EBITDA fell by 73% to $2 million in Q4 2025, compared to $9 million in Q4 2024, indicating significant operational profitability challenges.
-
Revenue Growth Achieved
The company reported an 8% increase in Q4 2025 revenue to $418 million, with organic revenue growing by 5%, driven by momentum in skilled businesses.
-
Gross Margin Contracts
Gross margin decreased by 5 percentage points, primarily due to lower workers' compensation benefit from prior year reserves and changes in business mix.
auto_awesomeAnalysis
TrueBlue's fourth-quarter results present a mixed picture, with revenue growth overshadowed by a substantially wider net loss and a sharp decline in Adjusted EBITDA. The $18 million non-cash impairment charge significantly impacted the net loss, while gross margin contraction points to underlying operational pressures. Although the company achieved organic revenue growth and improved SG&A, the overall profitability metrics deteriorated. The Q1 2026 outlook anticipates continued revenue growth but also a further decline in gross margin. These results are particularly critical given the ongoing proxy contest initiated by EHS Management, as they will heavily influence investor sentiment and the company's strategic defense.
At the time of this filing, TBI was trading at $3.85 on NYSE in the Trade & Services sector, with a market capitalization of approximately $135.3M. The 52-week trading range was $3.45 to $7.86. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.